Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder (Respirent Pharmaceuticals)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder (Respirent Pharmaceuticals), covering 2023-04-06 to 2023-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma [Phase 3]